Publications

ARVThe First Child on ARVs 
Abdool Karim S, Abdool Karim Q, Friedland G, Lalloo U and El-Sadr W on behalf of the START Project: Implementing Antiretroviral Therapy in Resource Constrained Settings: Opportunities and Challenges in Integrating HIV and Tuberculosis Care. AIDS 2004; 18:975-979.

Friedland G, Abdool Karim S, Abdool Karim Q, Lalloo U, Jack C, Gandhi N, El-Sadr W: The Utility of Tuberculosis Directly Observed Therapy (DOT) Programs as Sites for Access and Provision of Antiretroviral Therapy in Resource Limited Settings. Clinical Infectious Diseases, 2004; 38 (Suppl 5):S421-S428.

Uebel K, Friedland G, Pawinski R, Holst H: HAART for hospital health care workers an innovative programme. South African Medical Journal 2004; 94(6):423-427.

Jack C, Lalloo U, Abdool Karim Q, Abdool l Karim S, El-Sadr W, Cassol S, Friedland G: A Pilot Study of Once Daily Antiretroviral Therapy Integrated with Tuberculosis Directly Observed Therapy (TBDOT) In A Resource Limited Setting. Journal of Acquired Immune Deficiency Syndromes 2004; 36:929-934.

Gandhi N, Moll A, Sturm AW, Pawinski R, Govender T, Lalloo U, Zeller K, Andrews J, Friedland GH: Extensively Drug-Resistant Tuberculosis (XDR TB) as a Cause of Death among TB/HIV Co-infected Patients in a Rural Area in South Africa. The Lancet 2006; 368:1575–80.

Friedland GH, Khoo S, Jack C, Lalloo U: Administration of Efavirenz (600 mg/day) with Rifampin Results in Highly Variable Levels Which do not Predict Clinical Outcomes in Patients Treated for Tuberculosis and HIV. Journal of Antimicrobial Chemotherapy 2006; 58:1299–1302

Shah NS, Wright A, Bai G-H, Barrera L, Boulahbal F, Martín-Casabona N, et al. Worldwide emergence of extensively drug-resistant tuberculosis. Emerging Infectious Diseases 2007 (13): 380-387

Friedland G: Tuberculosis, Drug Resistance and HIV/AIDS: Triple Threat. Current Infectious Diseases Reports 2007; 9:252-261.

Friedland G, Harries A, Coetzee D: Implementation Issues in HIV-TB Collaboration and Integration. Journal of Infectious Diseases, 2007; 196 (Suppl 1): S114-S123.

Andrews J, Shah NS, Gandhi N, Moll A, Friedland G: Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: Implications for the HIV Epidemic and Antiretroviral Therapy Roll-Out in South Africa. Journal of Infectious Diseases, 2007; 196(Suppl 3): S482-S490.

Tsiouris S, Gandhi N, El-Sadr W, Friedland G: Tuberculosis and HIV – Needed: A New Paradigm for the Control and Management of Linked Epidemics. eJIAS: eJournal of the International AIDS Society. Medscape General Medicine. 2007; 9(3):62.

Basu S, Andrews J, Poolman E, Gandhi N, Shah S, Moll A, Moodley P, Galvani A, Friedland G: Prevention of Nosocomial Transmission of Extensively Drug-resistant Tuberculosis in Rural South African District Hospitals: An Epidemiological Modeling Study. The Lancet 2007; 370:1500-1507.

Shiferaw G, Woldeamanuel Y, Shah NS, Gebyehu M, Selassie A, Lemma E. Microscopic-Observation Drug-Susceptibility Assay Provides Rapid and Reliable Identification of Multidrug-Resistant Tuberculosis. International Journal of Tuberculosis and Lung Diseases. 2008;12:332-337.

Shah NS, Pratt R,Armstrong L, Robison V, Castro KG, Cegielski JP. Extensively Drug-Resistant Tuberculosis in the United States, 1993-2007. Journal of the American Medical Association 2008;300(18):2153-2160.

Friedland G: Protecting Health Care Workers; the Critical Role of Airborne Infection Control, Editorial. The International Journal of Tuberculosis and Lung Disease 2008; 12(6):585.

Padayachi N, Friedland G: Decentralised Management of Drug-Resistant Tuberculosis (MDR and XDR TB) In South Africa: An Alternate Model of Care. The International Journal of Tuberculosis and Lung Disease 2008; 12(8):978-980.

Andrews J, Gandhi N, Moodley M, ,Shah S, Bohlken L Moll A Pillay M, Friedland G, Sturm W: Exogenous Re-infection with Multidrug- and Extensively Drug-Resistant Tuberculosis Among Patients Receiving Treatment for Tuberculosis in Rural KwaZulu Natal, South Africa, Journal of Infectious Diseases 2008; 198(1 December):1582-9.

Gandhi N, Moll A, Lalloo U, Pawinski R, Zeller K, Moodley P, Meyer E, Friedland G: Successful Integration of Tuberculosis and HIV Treatment in Rural South Africa: the Sizonq’oba Study, Journal of Acquired Immunodeficiency Syndrome 2009;50:37-43.

Shenoi S, Heysell S, Moll T, Friedland G: Multidrug Resistant and Extensively Drug Resistant TB: Consequences for the Global HIV Community, Current Opinion in Infectious Diseases 2009;22:11-17.

Friedland, G: Tuberculosis Immune Reconstitution Inflammatory Syndrome: Drug Resistance and the Critical Need for Better Diagnostics, Clinical Infectious Diseases 2009; 48:5:677-679.

Reid M, Shah NS. Tuberculosis Screening among HIV-infected Persons in Resource-Limited Settings: Challenges of Current Diagnostic Tests. Lancet Infectious Diseases. 2009;9:173-184.

Orenstein EW, Basu S, Shah NS, Andrews JR, Friedland, GH, Moll AP, Gandhi NR and Galvani AP, Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysis, Lancet Infectious Diseases 2009; 9:153-161

Shenoi S, Friedland G: Extensively Drug-Resistant Tuberculosis: A new face to an old pathogen Annual Reviews of Medicine 2009;60:307-320.

Shah NS, Demissie M, Lambert LA, Ahmed J, Kebede T, Melaku Z, Luleseged S, Lemma E, Wells CD, Wuhib TW, Nelson LJ. Intensified Tuberculosis Case Finding among HIV-infected Persons from a Voluntary Counseling and Testing Center in Addis Ababa, Ethiopia. Journal of .Acquired Immunodeficiency Syndrome 2009;50:537-545.

Basu S, Friedland G, Andrews J, Shah S, Gandhi N, Moll A, Moodley P, Sturm W, Medlock, Galvani A. The Emergence and Transmission Dynamics of XDR Tuberculosis in Rural KwaZuluNatal, South Africa, Proceedings of the National Academy of Science, 2009; 106(18):7672-7677s)

Gandhi NR, Shah NS, Andrews JR, Vella V, Moll AP, Scott M, Weissman D, Marra C, Lalloo UG, Friedland GH: HIV Co-infection in Multidrug- and Extensively Drug-Resistant Tuberculosis Results in High Early Mortality. American Journal of Respiratory and Critical Care Medicine. 2010; 181:80-86.

Abdool Karim SS, Naidoo K, Grobler A, Padayatchi N, Baxter C, Gray A, Gengiah T; Nair G, Bamber S, Singh A, Khan M; Pienaar J,El-Sadr W, Friedland G, Abdool Karim Q: Timing of Initiation of Antiretroviral Drugs During Tuberculosis Therapy. New England Journal of Medicine. February 25, 2010; 362(8):697-706.

Simon M, Altice F, Moll A, Shange M, Friedland G: Preparing for highly-active antiretroviral therapy rollout in rural South Africa: an assessment using the information, motivation, and behavioral skills model. AIDS Care. March 05, 2010. Article: DOI: 10.1080/09540120903220253 URL: http://dx.doi.org/10.1080/09540120903220253

Churchyard GJ, Friedland G, Fielding K, Nardell E: Opportunities afforded by new drugs for tuberculosis. The Lancet Infectious Diseases, 2010; 10(6):368-9.

Heysell SK, Moll AP, Gandhi NR, Eksteen FJ, Babaria P, Coovadia Y, Roux L, Lalloo U, Friedland G and Shah NS. Extensively Drug-resistant Mycobacterium Tuberculosis from Aspirates, Rural South Africa. Emerging Infectious Diseases www.cdc.gov/eid 2010; 16(3):557.

Shenoi, S, Escombe AR, Friedland G: Transmission of Drug-Susceptible and Drug-Resistant Tuberculosis and the Critical Importance of Airborne Infection Control in the Era of HIV Infection and Highly Active Antiretroviral Therapy Rollouts Clinical Infectious Diseases, 2010; 50(Suppl 3):S231-237.

Shenoi S, Thomas T. Friedland GH: Surveillance and Management of HIV/TB Coinfection. Infections in Medicine. AIDS Care 4, Mar, 2010.

Wallis RS, Jakubiec WM, Kumar V, Silvia AM, Paige D, Dimitrova D, Li X, Ladutko L, Campbell S, Friedland G, Mitton‐Fry M, and Miller PF: Pharmacokinetics and whole blood bactericidal activity against Mycobacterium tuberculosis of single doses of PNU‐100480 in healthy volunteers, Journal of Infections Diseases 2010;202(5): 745-751

Thomas T, Shenoi S, Heysell S, Eksteen F, Sunkari V, Gandhi N, Friedland G, Shah S. Extensively Drug-Resistant Tuberculosis in Children with HIV from Rural South Africa International Journal of Tuberculosis and Lung Diseases (In press)

Brust J, Lygizos M, Chaiyachati K, Scott m, van der Merwe T, Moll A, Li X, Loveday m, Bamber S, Lalloo U, Friedland G, Shah S and Gandhi N: Culture Conversion among HIV Co-infected Multidrug-Resistant Tuberculosis. PLoS ONE. (In press).